This site uses cookies to store information on your computer. Learn more x

DSM in Medical

DSM in the news 2010

News articles 2017 | 20162015 | 20142013 | 2012 | 2011 | 2010 | 2009 | 2007

Ultra-High-Molecular-Weight Polyethylene Technology for Minimally Invasive Devices (Medical Design Briefs Sep 2010)

September 2010 - Ultra-thin film and fiber are suitable for implantable cardiovascular devices. Ultra-high-molecular-weight polyethylene (UHMWPE) has been used for decades as a biomaterial in joint replacements. Recently, this technology was refined to service the needs of minimally invasive surgical applications, particularly cardiovascular implants.

DSM and Japanese National Institute for Materials Science (NIMS) to collaborate on research in biomedical materials science

July 2010 - DSM and Japanese National Institute for Materials Science (NIMS) to collaborate on research in biomedical materials science.

DSM brings innovative polymers to Ortho Manufacturers

August 2010 - DSM Biomedical (Berkeley, CA) is providing orthopaedic manufacturers with its PTG polymers, which are suitable for chronic implant applications. Multiyear licensing agreements will allow DSM to work with companies throughout various phases of development, prototyping, manufacturing, and processing of product commercialization.More>

Building a better implant

July/August 2010 - When Bob Ward cofounded The Polymer Technology Group (PTG) in 1989, he saw a medical device crisis looming. Suppliers of the materials used to make these devices were alarmed by massive class-action lawsuits related to bodily injuries resulting from implants, including jawbone and breast implants. As these ‘biomaterial’ suppliers pulled out of the medical market, the device manufacturers were left unsure where they might source specialized materials in the future for artificial hearts, pacemakers, and intra-aortic balloon pumps.

Amino acid-containing degradable polymers & their potential in controlled drug delivery

May 2010 - Biodegradable polymers allow for avoidance of re-interventions related to removal of the drug delivery implant, and therefore minimize risk of complications and adverse events associated with long-term implantable materials. However, it should be noted that these benefits have to be weighed against potential risks caused by degradation products and intermediates.

DSM Biomedical: Providing solutions for the Biopharma & Medical Device Industries

April 2010 - DSM Biomedical is a global leader in biomedical materials that provides proprietary materials-based solutions, designed to enable new and more effective patient treatments for the medical device and biopharmaceutical industries. Building on the expertise and strengths of DSM and its 2008 acquisition of The Polymer Technology Group (now known as DSM PTG), DSM Biomedical’s product portfolio includes coatings, drug delivery platforms, and a wide range of biomedical materials for use in short- and longterm implantable medical devices.

What's hip in Orthopedic Implant Design

April 14, 2010 - In hip implants, where wear resistance is key, each combination of bearing surfaces has unique advantages and distinct drawbacks. When it comes to arthritis in the hip joint, patients no longer have to grin and bear it. Instead, hip implants replace damaged natural bearing surfaces with artificial ones in order to alleviate pain and improve quality of life for patients. More>

Innovation improves healthcare quality

March 2010 - As one of the top four leading causes of death in US hospitals, nosocomial infections must be regarded as a serious health hazard. Antimicrobial coatings can help prevent infection and aid in restoring a patient to full health.

Medical coatings and surfaces: Where worlds collide

March 2010 - This review of surface solutions describes some of the latest technologies available to improve device performance. These include a non-biofouling technology that offers mechanical durability and the inhibition of microbial adhesion, as well as technology that modifies rather than coats the polymer from which a device is fabricated. More>

Medical polymer for chronic implants

March 12, 2010 - DSM PTG, part of DSM Biomedical, introduces Bionate® II PCU, a versatile medical polymer with built-in surface technology designed for chronic implants. Bionate® II PCU is a line extension of the Bionate®Polycarbonate Urethane family, a medical polymer for long-term implants and is backed by an established FDA Master File.More>

Plastic medical devices market is growing. Antimicrobial plastics used in medical devices prevent hospital related Infections

March 3, 2010 - The market for plastic medical devices is growing despite the global economic slowdown. The medical device market is therefore quite optimistic to achieve double digit growth at 15% in Asia, 10-12% in America, and 6-8% in Europe for 2009 and 2010. Although medical devices may differ widely in design and use characteristics, certain factors determine susceptibility of a device to microbial contamination and biofilm formation: duration of use, number and type of organisms to which the device is exposed, flow rate and composition of the medium in or on the device, device material construction and conditioning films on the device.More>